UPC_APP_17784/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Procedural & sub-applicationsWithdrawal ApplicationsMilan CDApplication Rop 265—Settled at: Pre-merits

Overview Decisions Documents Timeline

Parties

Claimants

Pfizer, Inc.
Pfizer Europe MA EEIG
Pfizer B.V.
Pfizer S.A.
Pfizer Manufacturing Belgium S.A.
Pfizer Service Company S.R.L.
Pfizer Pharma GmbH
Pfizer Limited

Reps: Gareth Williams (Marks & Clerk LLP)

Respondents

GlaxoSmithKline Biologicals SA

Reps: Oliver Jan Juengst (Bird & Bird LLP); Daniela Kinkeldey (Bird & Bird LLP)

Judges

Andrea PostiglionePresiding Judge
Anna-Lena KleinJudge-Rapporteur
Steen Lyders Wadskov-HansenTechnically Qualified Judge

Patents

EP 4 183 412

CPC codes: C12N2760/18522, C12N2760/18534, A61K2039/55505, A61K2039/5258, A61K2039/55566, A61K39/155, A61K39/12, C07K2319/73, A61K2039/53, C07K2317/76, A61P31/14, A61P37/04…

Sector: Biotechnology

Outcome

Withdrawn

Filed: —

First decided: Apr 22, 2025

Language: —

Settled at: Pre-merits

Order by Milan Central Division (UPC_CFI_687/2024, 22 April 2025) permitting Pfizer's withdrawal of the revocation action and counterclaim for revocation against GlaxoSmithKline's EP 4 183 412 (RSV F protein vaccine), and permitting GlaxoSmithKline to withdraw its patent amendment application. 60% court fee reimbursement was granted; each party bears its own costs.